The largest community of pharma leaders

Kraig Biocraft Laboratories Selects Second New Member for Expanded Board of Directors

ANN ARBOR, Mich.–()–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has selected Ms. Julie Bishop for its expanded Board of Directors. Ms. Bishop currently serves as the Senior Director of Global Accounting at Verizon Media and has held senior accounting positions at Yahoo and HD Waterworks. Prior to this, Ms. Bishop spent seven years serving as an auditor for publicly traded companies while working at Ernst & Young.

“We are pleased to welcome Julie, who will be joining the Kraig Lab’s board, as a new independent director,” said chairman and CEO, Kim Thompson. “Julie’s background, experience, and leadership, in corporate finance, accounting, merger and acquisitions, and audit, will be a tremendous asset to our corporate governance as we continue on our growth trajectory.”

The addition of Ms. Bishop to the board will expand the overall skillset, perspective and experience necessary to support and drive growth for all of the Company’s stakeholders. Ms. Bishop is a licensed C.P.A. with extensive experience in finance and auditing for publicly traded companies.

Ms. Bishop’s term will begin during the fourth quarter and she will serve on the audit and compensation committees for the duration of her time as a director.

“I am thrilled to have been selected for appointment to the Kraig Labs Board of Directors,” said Ms. Bishop. “I look forward to helping oversee the company as it moves to commercialize its next generation protective textile products and realize the potential of its cutting edge technology.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Source

Recent Articles

Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Receives ADLT Status for Envisia Genomic...

TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals comments on animal studies in the development...

TTG Welcomes Bruce Anneaux to the Executive Team

HIGGINSVILLE, Mo.--(BUSINESS WIRE)-- #airadigmadventure--TTG has hired Dr. Bruce Anneaux as the...

Free, Automated Identification of Financial Aid for COVID-19 Treatment: Atlas Health Helps Hospitals, Uninsured & Underinsured Patients Mitigate “Surprise” Bills

SAN FRANCISCO--(BUSINESS WIRE)--Free, Automated Identification of Financial Aid for COVID Treatment:...

Zelis and Concert Genetics Launch Genetic Testing Claim Editing Solution

BEDMINSTER, N.J. & NASHVILLE, Tenn.--(BUSINESS WIRE)-- #HealthcareIndustry--Zelis, the healthcare industry’s leading...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.